Critical review of the use of erythropoietin in the treatment of anaemia during therapy for chronic hepatitis C
Impact of erythropoietin on sustained virological response to peginterferon and ribavirin therapy for HCV infection: a systematic review and meta–analysis
Characterization of nonrapid virologic response patients infected with HCV genotype 1 who may relapse after standard therapy with peginterferon plus ribavirin
Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus
Intravenous drug use: not a barrier to achieving a sustained virological response in HCV infection
Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa–2b
CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon–α therapy and toll–like receptor 3 signalling
Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion
Characterizing hepatitis B stigma in Chinese immigrants
Preactivation of the interferon signalling in liver is correlated with nonresponse to interferon alpha therapy in patients chronically infected with hepatitis B virus
The tumour necrosis factor–α–238A allele increases the risk of chronic HBV infection in European populations
Virologic factors associated with failure to passive–active immunoprophylaxis in infants born to HBsAg–positive mothers
Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells
Comparison of the hepatitis B virus core, surface and polymerase gene substitution rates in chronically infected patients
Pretreatment HBeAg level and an early decrease in HBeAg level predict virologic response to entecavir treatment for HBeAg–positive chronic hepatitis B
Impact of hepatitis B virus infection on metabolic profiles and modifying factors
Serum microRNA–122 levels in different groups of patients with chronic hepatitis B virus infection
Tumour necrosis factor–α–857T allele reduces the risk of hepatitis B virus infection in an Asian population
Inhibition of IκB kinase by thalidomide increases hepatitis C virus RNA replication
Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity
Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation
Longitudinal changes of the laboratory data of chronic hepatitis C patients with sustained virological response on long–term follow–up
Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients
Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hepatitis C virus genotype 1b infection
Peginterferon alfa–2b plus weight–based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response
Serum PAI–1 is a novel predictor for response to pegylated interferon–α–2b plus ribavirin therapy in chronic hepatitis C virus infection
Efficacy and safety of telaprevir, a new protease inhibitor, for difficult–to–treat patients with genotype 1 chronic hepatitis C
Fibrosis progression under maintenance interferon in hepatitis C is better detected by blood test than liver morphometry
Hepatic expression of MxA and OAS1 in an ex vivo liver slice assay independently predicts treatment outcomes in chronic hepatitis C
Examining hepatitis c virus testing practices in primary care clinics
Hepatic iron overload is common in chronic hepatitis B and is more severe in patients coinfected with hepatitis D virus
Immunohistochemistry for the diagnosis of hepatitis E virus infection
Transient elastography for predicting clinical outcomes in patients with chronic liver disease
Predictors of outcome in children with acute viral hepatitis and coagulopathy
The association of HIV viral load with indirect markers of liver injury
Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta–analysis
Ischaemic colitis during interferon treatment for chronic hepatitis C: report of two cases and literature review